Apria Inc
NASDAQ:APR
Apria Inc
NASDAQ:APR
Price:
37.5 USD
0.03%
Updated:
May 2, 2024
Apria Inc
Revenue
|
Apria Inc
Revenue Peer Comparison
Comparables:
DVA
DGX
CVS
CI
LH
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Apria Inc
NASDAQ:APR
|
Revenue
$1.1B
|
CAGR 3-Years
1%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
DaVita Inc
NYSE:DVA
|
Revenue
$12.1B
|
CAGR 3-Years
2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
0%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Revenue
$9.3B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
4%
|
CAGR 10-Years
3%
|
|
|
CVS Health Corp
NYSE:CVS
|
Revenue
$357.8B
|
CAGR 3-Years
10%
|
CAGR 5-Years
13%
|
CAGR 10-Years
11%
|
|
|
Cigna Corp
NYSE:CI
|
Revenue
$195.3B
|
CAGR 3-Years
7%
|
CAGR 5-Years
32%
|
CAGR 10-Years
20%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Revenue
$12.3B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
2%
|
CAGR 10-Years
8%
|
Apria Inc
Revenue Breakdown
Breakdown by Geography
Apria Inc
Apria Inc
Not Available
Breakdown by Segments
Apria Inc
Apria Inc
|
Total Revenue:
1.1B
USD
|
|
Fee-For-Service Arrangements:
917.7m
USD
|
|
Obstructive Sleep Apnea Treatment:
293.4m
USD
|
|
Other Equipment And Services:
44.8m
USD
|
|
Negative Pressure Wound Therapy:
4m
USD
|
|
Home Respiratory Therapy:
2.7m
USD
|
See Also
What is Apria Inc's Revenue?
Revenue
1.1B
USD
1.1B
USD
Based on the financial report for Dec 31, 2021, Apria Inc's Revenue amounts to 1.1B USD.
What is Apria Inc's Revenue growth rate?
Revenue CAGR 3Y
1%
1%
Over the last year, the Revenue growth was 3%. The average annual Revenue growth rates for Apria Inc have been 1% over the past three years .
You don't have any saved screeners yet
